Interstitial Lung Disease (ILD) Treatments
The University of Pittsburgh Simmons Center for Interstitial Lung Disease at UPMC specializes in managing environmental and other lung diseases. We offer the multidisciplinary approach needed to treat patients and prevent progression of lung disease, when possible.
The treatment team
Patients are evaluated by the Simmons Center team, that includes:
- Pulmonary physicians — who have expertise in the field of environmental and occupational health
- Industrial hygienists — who assess the work place, and outdoor and indoor environments (these services are usually not covered by insurance companies)
- Cardiologists — who evaluate the involvement of the heart and pulmonary vessels
- Rheumatologists — who assess the immune system
- Pathologists — who evaluate the biopsies
- Chest radiology experts — who evaluate imaging results
- Rehabilitation and quality-of-life experts — who optimize supportive therapy and assess the psychological impact of ILD
- UPMC lung transplant surgeons — for cases when medical treatment is not effective and the disease is expected to progress
- Leaders in clinical research — who provide access to novel ILD therapies
Treatment options for interstitial lung disease
Our team will periodically re-evaluate patient progress and assess the treatment options once the diagnosis of occupational- or environmental-induced lung disease is confirmed.
There are no approved drug therapies for many people with these diseases, but most patients benefit from:
UPMC is a world leader in lung transplantation and experts at the Lung Transplantation Program evaluate patients rigorously to determine their eligibility for this procedure.
Doctors at the Simmons Center work closely with members of the Lung Transplant Program to refer patients for evaluation, when the time is right.
Participation in clinical research is one of the major benefits of referral to large specialized centers in occupational lung diseases such as UPMC.
While there are currently no proven effective medications for most occupational lung diseases, novel drugs are being tested continuously.
Participating in research studies directly contributes to finding a cure for these preventable, but devastating, illnesses.